Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenue:
Licensing revenue		$ 250,000		$ 250,000
Expenses:
Research and development	374	(485)	1,430	577,843
General and administrative	1,546,213	2,360,996	4,814,436	6,514,107
Total operating expenses	1,546,587	2,360,511	4,815,866	7,091,950
Loss before other income (expense)	(1,546,587)	(2,110,511)	(4,815,866)	(6,841,950)
Other income (loss):
Interest income	91,403	93,391	283,808	269,299
Interest expense		(363,086)		(1,715,733)
Other income (loss), net	(35,598)	(1,502)	(37,919)	(13,230)
Gain on warrant derivative liabilities				527,025
Net loss from continuing operations	(1,490,782)	(2,381,708)	(4,569,977)	(7,774,589)
Gain (loss) from discontinued operations	19,243	(909,336)	397,955	(2,601,614)
Net loss	$ (1,471,539)	$ (3,291,044)	$ (4,172,022)	$ (10,376,203)
Basic and diluted loss per share
Continuing operations	$ (0.04)	$ (0.07)	$ (0.14)	$ (0.26)
Discontinued operations		(0.03)	0.01	(0.08)
Total basic and diluted loss per share	$ (0.04)	$ (0.10)	$ (0.13)	$ (0.34)
Basic and diluted weighted-average shares outstanding	33,249,904	32,991,506	33,249,904	30,242,788